Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
ILMN Illumina Inc. monthly Stock Chart
Illumina Inc.
Index- P/E44.47 EPS (ttm)3.27 Insider Own1.00% Shs Outstand144.70M Perf Week-0.26%
Market Cap21.04B Forward P/E37.20 EPS next Y3.91 Insider Trans-30.99% Shs Float143.34M Perf Month-29.41%
Income485.70M PEG2.21 EPS next Q0.79 Inst Own94.80% Short Float3.24% Perf Quarter-36.52%
Sales2.07B P/S10.16 EPS this Y163.30% Inst Trans1.04% Short Ratio2.39 Perf Half Y-23.64%
Book/sh12.44 P/B11.69 EPS next Y16.06% ROA14.10% Target Price199.05 Perf Year-3.06%
Cash/sh10.44 P/C13.93 EPS next 5Y20.15% ROE31.60% 52W Range130.00 - 242.37 Perf YTD-21.21%
Dividend- P/FCF60.66 EPS past 5Y34.90% ROI15.20% 52W High-40.00% Beta0.87
Dividend %- Quick Ratio2.80 Sales past 5Y22.80% Gross Margin71.00% 52W Low11.87% ATR8.76
Employees3700 Current Ratio3.10 Sales Q/Q20.50% Oper. Margin27.60% RSI (14)29.29 Volatility4.01% 5.05%
OptionableYes Debt/Eq0.73 EPS Q/Q122.60% Profit Margin23.50% Rel Volume0.68 Prev Close146.60
ShortableYes LT Debt/Eq0.56 EarningsOct 20 AMC Payout0.00% Avg Volume1.94M Price145.43
Recom2.10 SMA20-16.91% SMA50-24.25% SMA200-26.77% Volume1,318,452 Change-0.80%
Oct-13-15Reiterated Barclays Equal Weight $215 → $170
Oct-06-15Reiterated Stifel Buy $235 → $175
Oct-06-15Reiterated Piper Jaffray Overweight $230 → $220
Oct-06-15Reiterated Leerink Partners Mkt Perform $185 → $155
Oct-06-15Reiterated Goldman Neutral $230 → $137
Oct-06-15Downgrade Mizuho Buy → Neutral $250 → $150
Oct-01-15Downgrade Leerink Partners Outperform → Mkt Perform
Aug-27-15Initiated Cantor Fitzgerald Buy
Aug-19-15Reiterated Mizuho Buy $240 → $250
Jul-22-15Reiterated Mizuho Buy $230 → $240
Jul-22-15Reiterated Canaccord Genuity Buy $275 → $250
May-21-15Upgrade Morgan Stanley Equal-Weight → Overweight $162 → $190
Apr-22-15Reiterated Mizuho Buy $220 → $230
Mar-10-15Initiated UBS Buy $240
Jan-28-15Reiterated Stifel Buy $215 → $235
Jan-28-15Reiterated Maxim Group Buy $236 → $255
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Oct-13-15 12:58PM  [Podcast] The broad themes you need to know going into earnings season - from commodities to housing to biotech
Oct-08-15 04:13PM  Illumina (ILMN) Stock Could Light Up, Reversal in the Works at TheStreet
09:08AM  IBB and XBIs Top 10 Large-Cap Stocks Underperform
Oct-07-15 04:45PM  Illumina Sales Disappoint, Will Continue to Do So at Investopedia
03:59PM  Why Pacific Biosciences Pushed Higher Today at Motley Fool
01:00PM  Becton, Dickinson Launches FACSseq Single Cell Sorter
10:55AM  Illumina Fell 10.6% on a Biotech Sell-Off
08:25AM  Illumina (ILMN): Moving Average Crossover Alert
06:30AM  Illumina Introduces Genomics Solutions to Advance Clinical Research Business Wire
Oct-06-15 07:13PM  Dow ETF Cushioned By DuPont; Biotech Sell-Off Thickens at Investor's Business Daily -10.64%
04:39PM  Illumina Downgraded; Apple Supplier Skyworks PT Cut at Investor's Business Daily
04:38PM  Stocks Close Mixed as Biotech Slumps, Energy Jumps at TheStreet
04:20PM  Illumina (ILMN) Shares Tumble on Weak Outlook for Sales
04:04PM  The 52-Week Low Club for Tuesday
03:01PM  Biotechs take a beating
01:01PM  Videocast: Volatility levels decline
12:38PM  What's Wrong With Health Care? at
12:26PM  Why Illumina Is Down Big Today at Motley Fool
11:46AM  DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq at Investor's Business Daily
11:08AM  Big put sale sees floor in Illumina
10:45AM  Things Look Dark at Illumina at
10:36AM  Stocks Move Back Into Red as Biotech Sells Off Again at TheStreet
10:35AM  Stocks Wrestle In Mixed Action; DuPont Surges, Illumina Dives at Investor's Business Daily
10:13AM  More Pain For Biotech ETFs at
09:39AM  Illumina plummets after weak guidance
09:35AM  Heres Why These Three After-Market Lemons May Be Good Buys On The Dip at Insider Monkey
09:30AM  Edited Transcript of ILMN earnings conference call or presentation 5-Oct-15 8:30pm GMT
09:22AM  Cramer's Mad Dash: PMCS & SWKS
09:14AM  Stock Futures Down, Off Lows On News From DuPont, Pepsi, Illumina at Investor's Business Daily
09:03AM  Illumina (ILMN) Stock Continues Tumble on Sales Outlook at TheStreet
08:50AM  Top Analyst Upgrades and Downgrades: CBS, Cisco, Comerica, Twitter, FedEx, Illumina, Linn, NuVasive and Many More at 24/7 Wall St.
07:49AM  Early movers: PEP, ABC, DD, CSCO, BABA & more at CNBC
06:30AM  Illumina Expands Use of HiSeq X Sequencing System to Include Non-Human Species Business Wire
Oct-05-15 09:32PM  Trending Now: ILMN
05:26PM  Monday's After-Hours Movers Led By Du Pont, Arena Pharma, Illumina & Container Store Group
05:20PM  After-hours buzz: Illumina, DuPont & more at CNBC
05:07PM  Illumina Stock Dives On Latest Sales Warning at Investor's Business Daily
04:55PM  Illumina Poised on Product Innovation, Global Expansion
04:54PM  Illumina (ILMN) Stock Plummets in After-Hours Trading on Guidance at TheStreet
04:30PM  Mohawk Industries Inc Earnings Call scheduled for 4:30 pm ET today
04:25PM  Illumina Plunges 16% as Sales Slump at
04:08PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2015 Business Wire
08:02AM  Genomics Out Of 'Caveman Era,' But Still A Ways To Go at Investor's Business Daily
Oct-02-15 02:40PM  Illumina Downgraded by Leerink, Shares Plummet Over 10%
08:50AM  Weakness Seen in Illumina Inc. (ILMN): Stock Tumbles 10.6%
Oct-01-15 03:43PM  Illumina Tumbles On Downgrade, New Competition at Investor's Business Daily -10.58%
03:39PM  Why Illumina Fell Today at Motley Fool
02:23PM  Pacific Biosciences Has 'Long Road' Ahead, But Cantor Still Bullish
11:57AM  How Do Hedge Funds View These 3 Downgraded Stocks? at Insider Monkey
10:58AM  Stocks Give Up Early Gains As Apple, Illumina, Sucampo Slide at Investor's Business Daily
07:55AM  Analysts' Actions -- Allergan, Microsoft, Universal Health, World Wrestling Entertainment and More
06:30AM  Illumina Expands Worlds Largest Genomics Analysis Platform and Adds to Open Source Initiative Business Wire
Sep-30-15 08:00PM  Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer Diagnostics in China Business Wire
Sep-29-15 06:30AM  Illumina Launches TruSight® Tumor OncoPanel Business Wire
Sep-28-15 06:45AM  Put sale bets on floor in Illumina
Sep-25-15 06:27PM  Netflix, Google CEOs Top This Week's Insider Sales at Investor's Business Daily -6.77%
Sep-23-15 06:30AM  Illumina Joins WIN Consortium in Personalized Cancer Medicine Business Wire
Sep-21-15 03:08PM  Why at Least One Analyst Isnt Chasing Neogen
Sep-18-15 06:00PM  Why you don't hate biotech as much as tech yet at
Sep-17-15 07:47PM  Top Ten of XBI Outperform by Market Cap
04:00PM  Illumina in Partnership with Memorial Sloan to Develop ctDNA
Sep-16-15 06:30AM  Memorial Sloan Kettering Cancer Center and Illumina Launch Comprehensive Circulating Tumor DNA Program Business Wire
Sep-04-15 12:16PM  This Stock May be Biotech's Greatest Marvel
Sep-03-15 06:30AM  Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference Business Wire
Sep-02-15 02:50PM  Illumina Acquires GenoLogics, Boosts Genomic Sequencing
Sep-01-15 07:35AM  What Illumina Gets With GenoLogics Life Science Software
06:30AM  Illumina Completes Acquisition of GenoLogics Business Wire
Aug-28-15 04:34PM  Ambarella Leads 4 Top Stocks With Rising Estimates at Investor's Business Daily
Aug-27-15 12:41PM  Illumina (ILMN) Stock Initiated with a 'Buy' Rating at Cantor Fitzgerald at TheStreet
06:29AM  Coverage initiated on Illumina by Cantor Fitzgerald
Aug-26-15 03:40PM  Becton, Dickinson: Cellular Research Buy Adds to Genomics
Aug-24-15 09:00PM  Burning Rock and Illumina Collaborate on Molecular Diagnostics for Oncology Business Wire
05:54PM  LabCorp Reaching Past Doctor's Office To The Patient at Investor's Business Daily
09:25AM  RainDance pulls IPO citing market conditions at MarketWatch
Aug-20-15 02:30PM  Illumina (ILMN) Creates Helix to Encourage Genomics Startups
Aug-19-15 04:46PM  Google Gets YouTube Upgrade, Analog Devices PT Hiked at Investor's Business Daily
09:44AM  Illumina Creates Helix: Here's What It Is, And What It's Worth
Aug-18-15 05:41PM  Illumina Launches New Consumer-Genomics Startup at Investor's Business Daily
02:05PM  Gene-sequencing tech provider Illumina secures investors to create $100 million gene-sequencing venture Helix at
09:43AM  Illumina, Warburg Pincus Form Genetic-Testing Startup Helix at Bloomberg
03:01AM  Illumina partners with private equity firm on gene JV -sources Reuters
03:00AM  Illumina, Warburg Pincus, and Sutter Hill Ventures Form Helix to Accelerate Consumer Adoption of Genomics Business Wire
Aug-16-15 09:01AM  Billionaire Mandel Goes All-In On These Three Holdings at Insider Monkey
Aug-14-15 01:02PM  Short Sellers Wary Of Biotech Stocks
Aug-12-15 07:35AM  5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains at 24/7 Wall St.
Aug-09-15 09:02AM  3 Biotech Stocks to Buy in August at Motley Fool
Aug-06-15 01:04PM  ILLUMINA INC Financials
Aug-05-15 06:30AM  Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe Business Wire
Aug-04-15 04:05PM  Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market Business Wire
07:58AM  Gilead Sciences, Inc. Earnings Analysis: By the Numbers Q2*, 2015
Aug-03-15 08:09PM  10-Q for Illumina, Inc. at Company Spotlight
06:48PM  Big Cap Leaders Sail Past Earnings Season at Investor's Business Daily
Jul-31-15 04:31PM  ILLUMINA INC Files SEC form 10-Q, Quarterly Report
Jul-30-15 09:07AM  Large-Cap Healthcare Stocks Outperform Small Caps
09:01AM  Cramer on 2015's mixed signals
08:53AM  Celgene Corp. Earnings Analysis: By the Numbers
Jul-28-15 04:09PM  4 IBD 50 Stocks Poised To Bounce Back With Market
Jul-27-15 10:42AM  3 Signs That the Healthcare Stock Bubble Might Have Just Popped at Motley Fool
09:18AM  Illumina, Inc. Earnings Analysis: By the Numbers
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has a collaboration agreement with Merck Serono to develop a sequencing-based oncology diagnostic; Burning Rock to develop molecular diagnostics for oncology; and Memorial Sloan Kettering Cancer Center to develop of strategies to diagnose and monitor cancer, and establish ctDNA as an important marker in the study and eventual treatment of cancer. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRADBURY DANIELDirectorOct 07Option Exercise44.511,70075,66716,076Oct 07 07:46 PM
BRADBURY DANIELDirectorOct 07Sale145.811,700247,87814,376Oct 07 07:46 PM
WALT DAVID RDirectorSep 29Sale171.652,000343,29438,960Oct 01 05:47 PM
Dadswell CharlesSr VP & General CounselSep 28Sale173.2015727,19241,005Sep 28 07:11 PM
Klausner RichardSr VP, Chief Medical OfficerSep 28Sale173.2042373,26424,016Sep 29 04:26 PM
FLATLEY JAY TChief Executive OfficerSep 22Option Exercise27.9725,000699,250449,996Sep 23 12:42 PM
FLATLEY JAY TChief Executive OfficerSep 22Sale192.7925,0004,819,681424,996Sep 23 12:42 PM
WALT DAVID RDirectorSep 15Sale206.452,000412,89440,960Sep 17 07:39 PM
Bianchi Paul LSr. VP, Human ResourcesSep 09Sale199.321,245248,15358,519Sep 10 06:02 PM
FLATLEY JAY TChief Executive OfficerSep 08Option Exercise27.9725,000699,250449,996Sep 08 05:57 PM
EASTHAM KARINDirectorSep 08Option Exercise44.514,300191,39314,719Sep 08 06:02 PM
FLATLEY JAY TChief Executive OfficerSep 08Sale194.8725,0004,871,849424,996Sep 08 05:57 PM
EASTHAM KARINDirectorSep 08Sale195.764,300841,76810,419Sep 08 06:02 PM
WHITFIELD ROY ADirectorSep 04Option Exercise36.294,500163,30518,148Sep 09 07:56 PM
WHITFIELD ROY ADirectorSep 04Sale192.634,500866,83513,648Sep 09 07:56 PM
WALT DAVID RDirectorSep 01Sale195.082,000390,15142,960Sep 01 05:44 PM
FLATLEY JAY TChief Executive OfficerAug 27Option Exercise27.9725,000699,250449,996Aug 31 06:01 PM
Dadswell CharlesSr VP & General CounselAug 27Sale198.8116332,40641,162Aug 31 05:34 PM
FLATLEY JAY TChief Executive OfficerAug 27Sale200.1625,0005,004,125424,996Aug 31 06:01 PM
WALT DAVID RDirectorAug 18Sale206.892,000413,78544,960Aug 19 06:55 PM
BRADBURY DANIELDirectorAug 17Option Exercise75.661,700128,62216,076Aug 19 06:44 PM
BRADBURY DANIELDirectorAug 17Sale208.141,700353,84414,376Aug 19 06:44 PM
FLATLEY JAY TChief Executive OfficerAug 13Option Exercise27.9725,000699,250449,996Aug 13 06:51 PM
FLATLEY JAY TChief Executive OfficerAug 13Sale207.8525,0005,196,268424,996Aug 13 06:51 PM
Bouchard MichelChief Accounting OfficerAug 12Sale205.001,408288,64015,000Aug 13 06:03 PM
WALT DAVID RDirectorAug 11Sale208.695,4971,147,187648,840Aug 12 07:05 PM
EPSTEIN ROBERT SDirectorAug 10Option Exercise51.172,000102,3409,935Aug 12 06:46 PM
EPSTEIN ROBERT SDirectorAug 10Sale212.092,000424,1807,935Aug 12 06:46 PM
WHITFIELD ROY ADirectorAug 05Option Exercise37.244,500167,58018,148Sep 09 07:56 PM
WHITFIELD ROY ADirectorAug 05Sale215.224,500968,49013,648Sep 09 07:56 PM
WALT DAVID RDirectorAug 04Sale215.0310,0002,150,322654,337Aug 06 05:37 PM
WALT DAVID RDirectorAug 04Sale214.992,000429,98746,960Aug 06 05:37 PM
OSTADAN OMEADSr VP Product Dev & OperationsJul 29Option Exercise50.943,510178,78347,673Jul 31 05:29 PM
OSTADAN OMEADSr VP Product Dev & OperationsJul 29Sale217.933,510764,93445,673Jul 31 05:29 PM
WALT DAVID RDirectorJul 28Sale217.2910,0002,172,879664,337Jul 29 08:52 PM
Dadswell CharlesSr VP & General CounselJul 27Sale218.9216736,56041,325Jul 29 08:29 PM
BOWMAN A BLAINEDirectorJul 24Option Exercise39.143,000117,42016,615Jul 24 07:35 PM
BOWMAN A BLAINEDirectorJul 24Sale221.473,000664,40813,615Jul 24 07:35 PM
FLATLEY JAY TChief Executive OfficerJul 23Option Exercise27.9725,000699,250449,996Jul 24 07:19 PM
FLATLEY JAY TChief Executive OfficerJul 23Sale214.8725,0005,371,715424,996Jul 24 07:19 PM
WALT DAVID RDirectorJul 21Sale235.2410,0002,352,449674,337Jul 23 08:34 PM
WALT DAVID RDirectorJul 21Sale235.232,000470,46148,960Jul 23 08:34 PM
Ronaghi MostafaSr VP & CTOJul 17Sale235.001,200282,00041,856Jul 21 08:57 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 16Sale229.931,639376,85121,332Jul 17 06:29 PM
Ronaghi MostafaSr VP & CTOJul 15Sale231.581,000231,58042,056Jul 16 06:44 PM
Naclerio NicholasSr VP, Corporate DevelopmentJul 15Sale229.436,5911,512,20521,686Jul 17 05:19 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 15Sale229.483,751860,76222,971Jul 17 06:29 PM
WALT DAVID RDirectorJul 14Sale227.3910,0002,273,943684,337Jul 16 06:30 PM
Ronaghi MostafaSr VP & CTOJul 14Sale225.002,000450,00043,056Jul 16 06:44 PM
Stapley MarcSr VP & CFOJul 13Option Exercise36.302,40087,12020,298Jul 14 09:03 PM
Bouchard MichelChief Accounting OfficerJul 13Sale222.751,400311,85016,408Jul 14 08:41 PM
Stapley MarcSr VP & CFOJul 13Sale214.903,000644,70117,298Jul 14 09:03 PM
EPSTEIN ROBERT SDirectorJul 10Option Exercise51.172,000102,3409,935Jul 14 08:28 PM
EPSTEIN ROBERT SDirectorJul 10Sale219.812,000439,6207,935Jul 14 08:28 PM
OSTADAN OMEADSr VP Product Dev & OperationsJul 10Sale219.811,110243,98945,673Jul 14 08:05 PM
FLATLEY JAY TChief Executive OfficerJul 09Option Exercise27.9725,000699,250449,996Jul 10 05:10 PM
FLATLEY JAY TChief Executive OfficerJul 09Sale218.1025,0005,452,477424,996Jul 10 05:10 PM
WALT DAVID RDirectorJul 07Sale220.2210,0002,202,178694,337Jul 08 08:00 PM
WALT DAVID RDirectorJul 07Sale220.162,000440,32950,960Jul 08 08:00 PM
BRADBURY DANIELDirectorJul 06Option Exercise75.661,700128,62216,076Jul 07 02:03 PM
WHITFIELD ROY ADirectorJul 06Option Exercise39.144,500176,13018,148Jul 07 06:10 PM
BRADBURY DANIELDirectorJul 06Sale219.701,700373,48814,376Jul 07 02:03 PM
WHITFIELD ROY ADirectorJul 06Sale218.114,500981,47813,648Jul 07 06:10 PM
WALT DAVID RDirectorJun 30Sale217.6410,0002,176,449704,337Jun 30 05:56 PM
Dadswell CharlesSr VP & General CounselJun 29Sale215.6316034,50142,662Jun 29 06:30 PM
FLATLEY JAY TChief Executive OfficerJun 25Option Exercise32.6325,000815,750449,996Jun 26 04:28 PM
FLATLEY JAY TChief Executive OfficerJun 25Sale220.3425,0005,508,403424,996Jun 26 04:28 PM
BRADBURY DANIELDirectorJun 24Option Exercise75.661,700128,62216,076Jun 24 06:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 24Sale221.075,0841,123,90926,722Jun 24 05:25 PM
BRADBURY DANIELDirectorJun 24Sale221.231,700376,09814,376Jun 24 06:28 PM
WALT DAVID RDirectorJun 23Sale220.0910,0002,200,942714,337Jun 24 05:01 PM
WALT DAVID RDirectorJun 23Sale220.172,000440,33152,960Jun 24 05:01 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 17Sale215.713,751809,11231,806Jun 18 11:38 AM
WALT DAVID RDirectorJun 16Sale215.1410,0002,151,374724,337Jun 18 11:34 AM
Naclerio NicholasSr VP, Corporate DevelopmentJun 15Sale214.336,5901,412,45528,277Jun 15 07:49 PM
Bianchi Paul LSr. VP, Human ResourcesJun 15Sale215.833,408735,54961,123Jun 15 07:53 PM
Stapley MarcSr VP & CFOJun 12Option Exercise36.302,40087,12020,898Jun 15 07:38 PM
Bouchard MichelChief Accounting OfficerJun 12Sale216.111,400302,55415,008Jun 15 07:05 PM
Stapley MarcSr VP & CFOJun 12Sale214.903,000644,70117,898Jun 15 07:38 PM
FLATLEY JAY TChief Executive OfficerJun 11Option Exercise33.8025,000844,875449,996Jun 12 09:49 PM
FLATLEY JAY TChief Executive OfficerJun 11Sale216.4125,0005,410,350424,996Jun 12 09:49 PM
EPSTEIN ROBERT SDirectorJun 10Option Exercise51.172,000102,34011,460Jun 11 05:12 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 10Option Exercise69.3410,000693,40045,557Jun 11 06:28 PM
EPSTEIN ROBERT SDirectorJun 10Sale214.242,000428,4809,460Jun 11 05:12 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 10Sale214.9410,0002,149,41435,557Jun 11 06:28 PM
WALT DAVID RDirectorJun 09Sale213.4810,0002,134,778734,337Jun 11 09:15 PM
WALT DAVID RDirectorJun 09Sale213.642,000427,28554,960Jun 11 09:15 PM
WHITFIELD ROY ADirectorJun 05Option Exercise39.144,500176,13018,148Jun 08 02:41 PM
WHITFIELD ROY ADirectorJun 05Sale207.494,500933,70513,648Jun 08 02:41 PM
OSTADAN OMEADSr VP Product Dev & OperationsJun 04Sale206.25874180,26346,783Jun 05 08:06 PM
WALT DAVID RDirectorJun 02Sale204.4210,0002,044,150744,337Jun 04 07:18 PM
EASTHAM KARINDirectorJun 01Option Exercise39.145,000195,70015,419Jun 03 07:47 PM
EASTHAM KARINDirectorJun 01Sale205.245,0001,026,21611Jun 03 07:47 PM
BRADBURY DANIELDirectorMay 29Option Exercise75.661,700128,62216,076Jun 01 07:24 PM
BRADBURY DANIELDirectorMay 29Sale206.621,700351,25414,376Jun 01 07:24 PM
FLATLEY JAY TChief Executive OfficerMay 28Option Exercise33.8025,000844,875449,996May 29 07:05 PM
FLATLEY JAY TChief Executive OfficerMay 28Sale208.7825,0005,219,502424,996May 29 07:05 PM
Dadswell CharlesSr VP & General CounselMay 27Sale206.6217035,12541,652May 28 08:04 PM
WALT DAVID RDirectorMay 26Sale204.7410,0002,047,382752,427May 28 07:26 PM
WALT DAVID RDirectorMay 26Sale204.792,000409,58356,960May 28 07:26 PM